|
Orthologous residues
|
|
Bax (human): T167‑p, Bax iso5 (human): ‑, Bax iso8 (human): ‑, Bax (mouse): T167‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
2D analysis, mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
HepG2 (hepatic), MEF (fibroblast) [IGF1R (mouse)]
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
staurosporine
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation, intracellular localization
|
|
Effect of modification (process):
apoptosis, induced
|